“…However, anticholinesterases have unfavourable drawbacks (hypersalivation, bradycardia, bronchoconstriction, nausea, vomiting, and abdominal cramps) that can be overcome through co‐administration of antimuscarinic agents (atropine or glycopyrrolate). Meanwhile, antimuscarinics also have unfavourable side effects like dry mouth, tachycardia, and blurred vision . Moreover, anticholinesterases are not capable of reversing deeper levels of NMB …”